Sep 15, 2020 / 08:15PM GMT
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director
Well, great. Good afternoon, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Very pleased to have UNITY with me for this next session.
Before we get started, I just want to read a brief disclaimer statement. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
So again, pleased to have UNITY with me for the next session. I'm going to turn it over to UNITY's CEO, Anirvan, and he's going to make some opening comments, and then we'll jump into Q&A.
Anirvan Ghosh - Unity Biotechnology, Inc. - CEO & Director
UNITY Biotechnology Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers